Results 141 to 150 of about 4,918 (159)

Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study

Diabetes, Obesity and Metabolism, 2010
Bo Ahren
exaly  

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2009
Masatoshi Kikuchi
exaly  

Fifty‐two‐week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

Diabetes, Obesity and Metabolism, 2009
Bo Ahren
exaly  

VILDAGLIPTIN

2010
openaire   +1 more source

Physicochemical Properties and Methods of Analysis of Vildagliptin (Review)

Pharmaceutical Chemistry Journal, 2022
exaly  

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

Endocrine Journal, 2011
Masanori Abe, Kazuyoshi Okada, Noriaki Maruyama   +2 more
exaly  

A concise and efficient synthesis of vildagliptin

Tetrahedron Letters, 2017
Giovanni Battista Giovenzana, Marco Baratella   +1 more
exaly  

The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers

British Journal of Clinical Pharmacology, 2008
Yanling He
exaly  

Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties

Expert Opinion on Investigational Drugs, 2006
Bo Ahren
exaly  

Vildagliptin in clinical practice: a review of literature

Expert Opinion on Pharmacotherapy, 2009
Moulinath Banerjee, Handrean Soran, Naveed Younis   +2 more
exaly